The importance of PTEN genomic status for prostate cancer prognosis is compelling but understanding its co-operation with other genetic aberrations in the context of this highly heterogeneous disease is crucial for accurately predicting clinical outcomes and developing targeted therapies. The gene discussed is PTEN; the disease is Familial prostate cancer.